AR024728A1 - Formulaciones de hormona de crecimiento. - Google Patents

Formulaciones de hormona de crecimiento.

Info

Publication number
AR024728A1
AR024728A1 ARP000103593A ARP000103593A AR024728A1 AR 024728 A1 AR024728 A1 AR 024728A1 AR P000103593 A ARP000103593 A AR P000103593A AR P000103593 A ARP000103593 A AR P000103593A AR 024728 A1 AR024728 A1 AR 024728A1
Authority
AR
Argentina
Prior art keywords
growth hormone
during storage
growth
temperatures
formulations
Prior art date
Application number
ARP000103593A
Other languages
English (en)
Spanish (es)
Original Assignee
Grandis Biotech Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315757&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR024728(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9916252.1A external-priority patent/GB9916252D0/en
Priority claimed from GBGB9918902.9A external-priority patent/GB9918902D0/en
Application filed by Grandis Biotech Gmbh filed Critical Grandis Biotech Gmbh
Publication of AR024728A1 publication Critical patent/AR024728A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
ARP000103593A 1999-07-12 2000-07-13 Formulaciones de hormona de crecimiento. AR024728A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9916252.1A GB9916252D0 (en) 1999-07-12 1999-07-12 Growth hormone formulation
GBGB9918902.9A GB9918902D0 (en) 1999-08-12 1999-08-12 Growth hormone formulation

Publications (1)

Publication Number Publication Date
AR024728A1 true AR024728A1 (es) 2002-10-23

Family

ID=26315757

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000103593A AR024728A1 (es) 1999-07-12 2000-07-13 Formulaciones de hormona de crecimiento.

Country Status (25)

Country Link
US (1) US20060029635A1 (cg-RX-API-DMAC7.html)
EP (1) EP1194170B1 (cg-RX-API-DMAC7.html)
JP (3) JP2003504346A (cg-RX-API-DMAC7.html)
KR (1) KR20020031388A (cg-RX-API-DMAC7.html)
CN (1) CN1360506A (cg-RX-API-DMAC7.html)
AR (1) AR024728A1 (cg-RX-API-DMAC7.html)
AT (1) ATE386501T1 (cg-RX-API-DMAC7.html)
AU (1) AU775107C (cg-RX-API-DMAC7.html)
BR (1) BR0013162A (cg-RX-API-DMAC7.html)
CA (1) CA2378949C (cg-RX-API-DMAC7.html)
CZ (1) CZ200260A3 (cg-RX-API-DMAC7.html)
DE (1) DE60038118T2 (cg-RX-API-DMAC7.html)
ES (1) ES2300268T3 (cg-RX-API-DMAC7.html)
HK (1) HK1046358A1 (cg-RX-API-DMAC7.html)
HU (1) HUP0202189A3 (cg-RX-API-DMAC7.html)
IL (2) IL147253A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02000404A (cg-RX-API-DMAC7.html)
NO (1) NO20020151L (cg-RX-API-DMAC7.html)
NZ (1) NZ516507A (cg-RX-API-DMAC7.html)
PL (1) PL353238A1 (cg-RX-API-DMAC7.html)
SI (1) SI1194170T1 (cg-RX-API-DMAC7.html)
SK (1) SK252002A3 (cg-RX-API-DMAC7.html)
TR (1) TR200200034T2 (cg-RX-API-DMAC7.html)
TW (1) TWI247608B (cg-RX-API-DMAC7.html)
WO (1) WO2001003741A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030162711A1 (en) * 1996-04-24 2003-08-28 Soren Bjorn Pharmaceutical formulation
US20070179096A1 (en) * 1996-04-24 2007-08-02 Novo Nordisk A/S Pharmaceutical Formulation
GB2371227A (en) * 2001-01-10 2002-07-24 Grandis Biotech Gmbh Crystallisation - resistant aqueous growth hormone formulations
EP1536835A1 (en) * 2002-07-09 2005-06-08 Sandoz AG Liquid formulations with high concentration of human growth hormone (hgh) comprising phenol
CA2516314C (en) * 2003-03-18 2012-01-03 Ares Trading Sa Liquid growth hormone formulation and process of preparation thereof
JP2007506683A (ja) * 2003-09-25 2007-03-22 カンジェーン コーポレイション ヒト成長ホルモン剤およびその調整方法と使用方法
WO2005063298A1 (en) * 2003-12-23 2005-07-14 Pharmacia Corporation Stable growth hormone liquid formulation
AU2005237775B2 (en) * 2004-04-07 2010-03-04 Ares Trading S.A. Liquid growth hormone formulation
US8293532B2 (en) 2009-03-26 2012-10-23 Dow AgroSciences, L.L.C. Method and apparatus for tissue transfer
EP2501367B1 (en) * 2009-11-17 2015-01-21 Ipsen Pharma S.A.S. Formulation for HGH and RHIGF-1 combination
EP2736490A1 (en) 2011-07-25 2014-06-04 Sandoz AG Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein
JP2013231030A (ja) * 2012-04-30 2013-11-14 Sun Pharmaceutical Industries Ltd リュープロリド注射剤
JP6001401B2 (ja) * 2012-09-28 2016-10-05 ユニ・チャーム株式会社 ウェットティッシュ用薬液及びウェットティッシュ
WO2017098798A1 (ja) 2015-12-10 2017-06-15 三菱瓦斯化学株式会社 光硬化性組成物及び光学材料
JP6172880B1 (ja) * 2017-02-01 2017-08-02 協和発酵キリン株式会社 ダルベポエチンを含む液体医薬組成物
EP3811962A4 (en) * 2018-06-25 2022-03-16 JCR Pharmaceuticals Co., Ltd. Protein-containing aqueous liquid formulation
EP4243770A1 (en) * 2020-11-16 2023-09-20 W. L. Gore & Associates, Inc. Formulations, methods, and pre-filled multi-dose injection devices without cloud point
CN112494638B (zh) * 2020-12-22 2023-12-19 深圳科兴药业有限公司 一种人生长激素注射剂组合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783441A (en) * 1979-04-30 1988-11-08 Hoechst Aktiengesellschaft Aqueous protein solutions stable to denaturation
DE3325223A1 (de) * 1983-07-13 1985-01-24 Hoechst Ag, 6230 Frankfurt Gegen denaturierung bestaendige, waessrige proteinloesungen, verfahren zu ihrer herstellung und ihre verwendung
EP0211601A3 (en) * 1985-07-30 1988-01-13 International Minerals And Chemical Corporation Stabilization of growth promoting hormones
US4857505A (en) * 1987-03-09 1989-08-15 American Cyanamid Company Sustained release compositions for parenteral administration and their use
IL86799A (en) * 1987-07-02 1993-03-15 Kabi Pharmacia Ab Method and device for injection
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
CA1331133C (en) * 1988-03-01 1994-08-02 Michael Jon Pikal Pharmaceutical growth hormone formulations
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
WO1994003198A1 (en) * 1992-07-31 1994-02-17 Genentech, Inc. Human growth hormone aqueous formulation
US5763394A (en) * 1988-04-15 1998-06-09 Genentech, Inc. Human growth hormone aqueous formulation
JPH0383931A (ja) * 1989-08-29 1991-04-09 Sumitomo Pharmaceut Co Ltd 低刺激性ｇｒｆ経鼻投与製剤
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
DK0549694T3 (da) * 1990-09-21 1995-10-16 Novo Nordisk As Adaptertop
SE9201073D0 (sv) * 1992-04-03 1992-04-03 Kabi Pharmacia Ab Protein formulation
US5334162A (en) * 1993-03-15 1994-08-02 Eli Lilly And Company Cartridge assembly for a lyophilized compound forming a disposable portion of an injector pen and method for same
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
US5610134A (en) * 1994-04-15 1997-03-11 Genentech, Inc. Treatment of congestive heart failure
JPH0892125A (ja) * 1994-09-21 1996-04-09 Nippon Chem Res Kk 水性医薬組成物
SE9502927D0 (sv) * 1995-08-24 1995-08-24 Pharmacia Ab Solution containing IGF-I
AUPN801296A0 (en) * 1996-02-12 1996-03-07 Csl Limited Stabilised growth hormone formulation and method of preparation thereof
ES2169351T3 (es) * 1996-02-13 2002-07-01 Searle & Co Combinaciones que tienen efectos inmunosupresores, que contienen inhibidores de ciclooxigenasa-2 y 5-lipoxigenasa.
ZA9711731B (en) * 1996-12-31 1998-07-01 Monsanto Co Aqueous glycerol formulations of somatotropin
IL122732A0 (en) * 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
JP3723857B2 (ja) * 1998-02-04 2005-12-07 日本ケミカルリサーチ株式会社 ヒト成長ホルモン含有水性医薬組成物

Also Published As

Publication number Publication date
WO2001003741A1 (en) 2001-01-18
JP2014208656A (ja) 2014-11-06
PL353238A1 (en) 2003-11-03
EP1194170B1 (en) 2008-02-20
ATE386501T1 (de) 2008-03-15
US20060029635A1 (en) 2006-02-09
BR0013162A (pt) 2002-05-28
DE60038118T2 (de) 2009-03-05
IL147253A0 (en) 2002-08-14
JP5941496B2 (ja) 2016-06-29
CA2378949A1 (en) 2001-01-18
AU775107B2 (en) 2004-07-15
HUP0202189A2 (en) 2002-10-28
WO2001003741B1 (en) 2001-04-19
TR200200034T2 (tr) 2002-05-21
NO20020151L (no) 2002-03-12
TWI247608B (en) 2006-01-21
HK1046358A1 (zh) 2003-01-10
CA2378949C (en) 2015-03-31
JP2003504346A (ja) 2003-02-04
IL147253A (en) 2007-07-24
SI1194170T1 (sl) 2008-10-31
CN1360506A (zh) 2002-07-24
MXPA02000404A (es) 2004-05-21
NZ516507A (en) 2004-02-27
CZ200260A3 (cs) 2002-04-17
AU5997500A (en) 2001-01-30
KR20020031388A (ko) 2002-05-01
NO20020151D0 (no) 2002-01-11
SK252002A3 (en) 2002-06-04
HUP0202189A3 (en) 2003-07-28
EP1194170A1 (en) 2002-04-10
AU775107C (en) 2005-02-24
DE60038118D1 (de) 2008-04-03
JP2012051891A (ja) 2012-03-15
ES2300268T3 (es) 2008-06-16

Similar Documents

Publication Publication Date Title
AR024728A1 (es) Formulaciones de hormona de crecimiento.
Contreras et al. Effects of short‐term storage on sperm function in fish semen: a review
AR040527A1 (es) Formulaciones de hgh en alta concentracion que contienen glicina
Chaveiro et al. Improvement of parameters of freezing medium and freezing protocol for bull sperm using two osmotic supports
Batellier et al. Advances in cooled semen technology
Saravia et al. Deep freezing of concentrated boar semen for intra-uterine insemination: effects on sperm viability
US4980277A (en) Cryoprotectant solution and method
Park et al. Comparison of semen characteristics, sperm freezability and testosterone concentration between Duroc and Yorkshire boars during seasons
ES2188607T3 (es) Composiciones enzimaticas liquidas estabilizadas.
US3005756A (en) Diluter containing carbon dioxide for preserving semen
White The toxicity of heavy metals to mammalian spermatozoa.
Koshimoto et al. The effect of the osmolality of sugar-containing media, the type of sugar, and the mass and molar concentration of sugar on the survival of frozen-thawed mouse sperm
US20100196872A1 (en) Semen extender composition and methods for manufacturing and using
Herold et al. Epididymal sperm from the African buffalo (Syncerus caffer) can be frozen successfully with AndroMed® and with Triladyl™ but the addition of bovine seminal plasma is detrimental
CN102578079A (zh) 马属动物精液稀释基础液及其配制方法和使用方法
CA2357108A1 (fr) Dilueur pour la conservation de spermatozoides de porcins
ATE554792T1 (de) Stabiles wachstumshormon-flüssigformulierung
PE3096A1 (es) Formulacion conteniendo selenio
CA2463681A1 (en) Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent
Saks The preservation of salt marsh algae by controlled liquid nitrogen freezing
CN113229288A (zh) 一种新型低温冷链季铵盐消毒剂及其制备方法
MXPA02010349A (es) Producto oftalmico coloreado.
JP2000119101A (ja) 豚精液保存用希釈液および豚精液の希釈保存法
CN117296830B (zh) 一种公猪精液的稀释液及其制备方法和用途
DeGraaf et al. Production and storage of sperm from the black sea bass Centropristis striata L

Legal Events

Date Code Title Description
FB Suspension of granting procedure